Stock listing
Aridis Pharmaceuticals Inc.
Selected listing: ARDS · OTC · USD · US
Aridis Pharmaceuticals Inc. (OTC:ARDS), Health Technology. Latest release Jun 24, 2024: Aridis Provides Corporate Update.
- Ticker
- OTC:ARDS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Aridis Pharmaceuticals Inc.
Aridis Pharmaceuticals Inc. (ticker: ARDS) is a public company based in the United States, focusing on innovative therapies for infectious diseases. The company aims to advance its pipeline of products to improve patient outcomes in critical areas of healthcare.
Latest news from Aridis Pharmaceuticals Inc.
Aridis Provides Corporate Update
June 23, 2024
Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024
December 14, 2023
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
November 2, 2023
OTC Markets Group Welcomes New OTCQB Companies – October 9
October 9, 2023
Reviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
September 21, 2023
Research Aridis Pharmaceuticals Inc.
Aridis Pharmaceuticals Inc. company profile
View the public company page for Aridis Pharmaceuticals Inc. on 6ix.
Aridis Pharmaceuticals Inc. news
Read company news and market updates connected to Aridis Pharmaceuticals Inc..
Aridis Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Aridis Pharmaceuticals Inc..